Related Experiment Video
Updated: Oct 29, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1
Jennifer A Janusz1, Bonita P Klein-Tasman2, Jonathan M Payne2
1From the Children's Hospital Colorado and University of Colorado School of Medicine (J.A.J.), Aurora; Department of Psychology (B.P.K.-T.), University of Wisconsin-Milwaukee; Murdoch Children's Research Institute and Department of Pediatrics (J.M.P., K.H.), University of Melbourne, Australia; Pediatric Oncology Branch (P.L.W., S.M., M.A.T.-T.), National Cancer Institute, Bethesda, MD; Department of Communication Sciences and Disorders (H.L.T.), California State University, Sacramento; University of Cincinnati Medical Center (P.d.B.), OH; Boston Children's Hospital (N.U.), MA; Children's National Hospital, Gilbert NF Institute (A.d.C., K.K.H., K.S.W.), Washington, DC; Children's Tumor Foundation (M.H.), New York, NY; The George Washington School of Medicine (K.K.H., K.S.W.), Washington, DC; Children's Hospital Los Angeles (T.R.), CA; and Leidos Biomedical Research, Inc. (M.A.T.-T.), Frederick, MD. jennifer.janusz@childrenscolorado.org.
Insights
This study recommends the Social Responsiveness Scale-2 (SRS-2) and the Social Skills Improvement System-Rating Scale (SSIS-RS) for assessing social deficits in children with neurofibromatosis type 1 (NF1). These tools aid in clinical trials for social skills development.
Area of Science:
- Neuroscience
- Pediatric Psychology
- Clinical Trial Methodology
Background:
- Social deficits are a significant concern in neurofibromatosis type 1 (NF1) affecting children and adolescents.
- Standardized, reliable measures are crucial for evaluating interventions in clinical trials for NF1.
- Existing social skills measures require evaluation for suitability in the NF1 population.
Purpose of the Study:
- To review parent-report social skills measures for children and adolescents (ages 6-18) with NF1.
- To identify and recommend consensus outcome measures for use in NF1 clinical trials.
- To guide the selection of appropriate social functioning assessments.
Main Methods:
- Conducted literature searches in PubMed and ClinicalTrials.gov for social skills measures.
- Included measures used in clinical trials for populations with social deficits (ADHD, ASD) within the last 5 years.
- Evaluated measures based on patient characteristics, study usage, domains, scores, psychometrics, and feasibility by the REiNS Neurocognitive Committee.
Main Results:
- The Social Responsiveness Scale-2 (SRS-2) and the Social Skills Improvement System-Rating Scale (SSIS-RS) were recommended.
- These two measures were identified as appropriate for clinical trials involving NF1.
- Each measure captures different facets of social functioning.
Conclusions:
- The SSIS-RS is suitable for studies on broader social functioning.
- The SRS-2 is optimal for research targeting ASD-associated social behaviors.
- Researchers should select measures based on specific study objectives for NF1 social deficit trials.
Objective:
To review parent-report social skills measures to identify and recommend consensus outcomes for use in clinical trials of social deficit in children and adolescents (ages 6-18 years) with neurofibromatosis type 1 (NF1).
Methods:
Searches were conducted via PubMed and ClinicalTrials.gov to identity social skills outcome measures with English language versions used in clinical trials in the past 5 years with populations with known social skills deficits, including attention-deficit/hyperactivity disorder and autism spectrum disorder (ASD). Measures were rated by the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) Neurocognitive Committee on patient characteristics, use in published studies, domains assessed, availability of standard scores, psychometric properties, and feasibility to determine their appropriateness for use in NF1 clinical trials.
Results:
Two measures were ultimately recommended by the committee: the Social Responsiveness Scale-2 (SRS-2) and the Social Skills Improvement System-Rating Scale (SSIS-RS).
Conclusions:
Each of the 2 measures assesses different aspects of social functioning. The SSIS-RS is appropriate for studies focused on broader social functioning; the SRS-2 is best for studies targeting problematic social behaviors associated with ASD. Researchers will need to consider the goals of their study when choosing a measure, and specific recommendations for their use are provided.
Related Concept Videos
Clinical Trials: Overview
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Clinical Trials
There are four phases in a clinical trial. A phase one...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

